Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kyowa Kirin
Biotech
Amgen ignites Rocket program with wins in phase 3 eczema trials
The data provide more evidence rocatinlimab improves outcomes, but questions about the antibody's positioning versus Dupixent remain unanswered.
Nick Paul Taylor
Mar 10, 2025 5:48am
Kura, Kyowa hail ph. 2 win for leukemia drug, but hold back data
Feb 6, 2025 10:40am
Kyowa Kirin fronts $330M to share rights to Kura's leukemia drug
Nov 21, 2024 9:35am
Biogen boosts C-suite with BMS vet—Chutes & Ladders
Nov 1, 2024 8:30am
Boehringer ends week with 3rd deal, this time with Kyowa Kirin
Jan 5, 2024 10:34am
Orchard lands $387M Kyowa buyout as gene therapy nears approval
Oct 5, 2023 9:20am
